Opko Health (OPK) Common Equity (2010 - 2026)

Opko Health (OPK) has 17 years of Common Equity data on file, last reported at $1.2 billion in Q2 2026.

• Quarterly Common Equity fell 8.69% year-over-year to $1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (down 8.69% YoY) and the FY2025 annual result came in at $1.3 billion, down 7.14% from the prior year.
• Common Equity declined to $1.2 billion in Q2 2026, from $1.2 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.7 billion in Q2 2022 to a low of $1.2 billion in Q2 2026.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2024 — Common Equity decreased 19.27% — and 2025, when it rose 4.7%.
• Tracing OPK's Common Equity over 5 years: stood at $1.6 billion in 2022, then fell by 11.04% to $1.4 billion in 2023, then declined by 1.71% to $1.4 billion in 2024, then dropped by 7.14% to $1.3 billion in 2025, then slipped by 6.61% to $1.2 billion in 2026.
• The last three Common Equity figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.